Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
May
8
2017
Texas Supreme Court Weighs In on Tied House McDermott Will & Emery
Jun
29
2017
FDA’s Delay of the Menu Labeling Rule Challenged McDermott Will & Emery
Sep
18
2017
Latest Decision in Kona Beer Branding False Advertising Case McDermott Will & Emery
Nov
22
2017
Looking Beyond the Label for Inducement in Post-Launch Case McDermott Will & Emery
Feb
15
2012
Has the Nuclear Renaissance Finally Begun? McDermott Will & Emery
Oct
20
2012
Commerce Department Announces New Duties on Chinese Solar Panel Imports McDermott Will & Emery
May
17
2021
European Commission and National Authorities Take a Stand Against Excessive Pricing by the Pharmaceutical Industry McDermott Will & Emery
May
9
2013
Bureau of Land Management Finalizes Segregation Rule for Wind and Solar Energy Projects McDermott Will & Emery
Jul
11
2013
Massachusetts Department of Energy Resources (DOER) Extends the Availability of Valuable Solar Carve-Out Program McDermott Will & Emery
Jun
1
2018
California Court of Appeal Holds That “Safe Harbor” Defense Precludes Suit Based on Presence of Inorganic Arsenic in Wines McDermott Will & Emery
Aug
4
2013
No Declaratory Judgment Jurisdiction Where Binding Assurances of No Litigation Eliminates Any Possible Justiciable Case or Controversy in Patent Case McDermott Will & Emery
Sep
16
2021
Material Information Submitted to FDA but Withheld from PTO Gives Rise to Inequitable Conduct McDermott Will & Emery
Oct
7
2013
Power Plant Cases in the Supreme Court McDermott Will & Emery
Dec
19
2013
European Commission Investigates Exemption from Renewable Energy Surcharge for Energy-Intensive Companies in Germany McDermott Will & Emery
Dec
10
2021
FDA Issues Draft Guidance On the Use and Curation of Real-World Data in Registries McDermott Will & Emery
Dec
16
2021
Rounding Error: Intrinsic Evidence Informs Plain and Ordinary Meaning McDermott Will & Emery
Jan
21
2014
California Issues Guidance on Nonprofit Property Owners Hosting Solar McDermott Will & Emery
Feb
15
2022
Treasury Responds to Biden Administration Executive Order With Report, Recommendations to Increase Alcohol Industry Competition [VIDEO] McDermott Will & Emery
May
29
2014
Combining Two Drugs Is Not Always Obvious: Sanofi-Aventis Deutschland GMBH v. Glenmark Pharmaceuticals Inc. McDermott Will & Emery
Jun
27
2014
Federal Judge Puts Narcolepsy Drug Horizontal Conspiracy Claims to Bed McDermott Will & Emery
Sep
30
2014
Post-Therasense IC Alive and Kicking at the Federal Circuit McDermott Will & Emery
Apr
12
2019
McDermottPlus Check-Up: April 12, 2019 McDermott Will & Emery
Apr
29
2019
TTB’s Take on Alcohol Beverages Infused with Cannabidiol McDermott Will & Emery
Dec
4
2014
An Update on EPA’s Approach to Methane Emissions from the Oil & Gas Sector – Including a Summary of the Agency’s Proposed New Reporting Rule McDermott Will & Emery
Jan
30
2015
No Declaratory Jurisdiction Without Biosimilarity Application on File with FDA McDermott Will & Emery
Jun
19
2019
Courts Are Siding with Employees Who Use Medical Marijuana McDermott Will & Emery
Feb
11
2015
FDA Will Not Enforce Regulatory Controls for Medical Device Data Systems and Two Other Health IT Devices McDermott Will & Emery
Jul
15
2019
European SPC Manufacturing Waiver Goes Into Force McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins